Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: A randomized, double-blind, placebo-controlled trial
A. Achiron, I. Kishner, I. Sarova-Pinhas, H. Raz, M. Faibel, Y. Stern, M. Lavie, M. Gurevich, M. Dolev, D. Magalashvili, Y. BarakVolume:
139
Year:
2005
Language:
english
Pages:
583
DOI:
10.1016/j.ajo.2004.12.093
File:
PDF, 37 KB
english, 2005